Table 1

Demographics of the study cohort

CharacteristicSurvivor,
N=148
Non-survivor/ITU/NIV,
N=39
P value
Age (18+), years55 (44–71)66 (60–76)<0.001
Sex0.7
 Male79 (53)22 (56)
 Female69 (47)17 (44)
PCR proven disease0.6
 Proven111 (75)31 (79)
 Suspected37 (25)8 (21)
Status at time of consent0.010
 Inpatient119 (80)38 (97)
 Outpatient29 (20)1 (2.6)
Diabetes status0.3
 No115 (78)34 (87)
 T1DM3 (2.0)1 (2.6)
 T2DM30 (20)4 (10)
Heart disease34 (23)12 (31)0.3
Chronic lung disease26 (18)20 (51)<0.001
Severe liver disease3 (2.0)2 (5.1)0.3
Severe kidney impairment (eGFR <30 or dialysis)16 (11)6 (15)0.4
Hypertension37 (25)15 (38)0.10
HIV status1 (0.7)1 (2.6)0.4
Non-white ethnicity20 (16)5 (15)0.9
  • Median (IQR); n (%).

  • Wilcoxon rank sum test; Pearson’s χ2 test; Fisher’s exact test.

  • eGFR, estimated glomerular filtration rate; ITU, Intensive Care admission; NIV, non-invasive ventilation; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.